This text comes directly from the complete editable business plan sold on this page, not from generic product-description copy.
Excerpt source: complete Total Artificial Heart Program Business Plan · Executive Summary section
EXECUTIVE SUMMARY
Scroll inside this frame to read the complete excerpt.
Houston TAH Institute — named to reflect our singular focus on Total Artificial Heart (TAH) therapy and our Houston base — is a medical institute launching in 2026 that operates in the cardiac surgery and long-term device-management sector. We provide a full-service clinical pathway: surgical implantation of TAH devices, intensive post-operative recovery, and lifelong outpatient device management. Our facility is a designated center of excellence with elite surgical teams and the most advanced cardiac equipment. We serve patients with end-stage biventricular heart failure and the referral network of cardiologists, transplant centers, and payers that support them. One-liner: We deliver end-to-end TAH care from implant to lifelong management.
Our core activities are patient evaluation and selection, TAH surgical implantation, ICU and step-down recovery, outpatient device monitoring, device servicing, and training for local providers. What sets us apart is concentrated expertise—specialist surgeons and dedicated TAH nursing and device teams—plus specialized infrastructure that improves outcomes and reduces complications. Short-term goals are to open in 2026, secure center-of-excellence certifications, and establish regional referral pathways. Long-term goals are to be a national referral hub, publish outcome data, and scale best-practice outpatient management protocols. One-liner: We aim to raise survival and quality-of-life standards for TAH patients nationwide.
Thousands of Americans face end-stage biventricular heart failure and many die waiting for donor hearts. Donor supply is chronically insufficient to meet need, leaving the sickest patients exposed to high mortality while on transplant waitlists.
Patients with biventricular failure are often ineligible for conventional transplant or deteriorate during long waits. Care is fragmented across general cardiac units, causing delayed mechanical support, limited access to Total Artificial Heart (TAH) expertise, and higher downstream costs from prolonged critical care.
We operate a comprehensive medical program centered on implantation and long-term management of Total Artificial Heart (TAH) devices that addresses the nationwide shortage of donor hearts and the gap in care for patients with end-stage biventricular heart failure. Our model combines pre-operative screening, complex surgical implantation, post-operative cardiac ICU care, outpatient device maintenance, and 24/7 remote monitoring to provide a full-cycle TAH care model that replaces donor-heart dependency.
One line: a full-cycle TAH care model that replaces donor-heart dependency.
Our mission is to give patients with end-stage heart failure a new lease on life by delivering unparalleled expertise in Total Artificial Heart (TAH) technology, combining surgical innovation with compassionate, patient-centered care. We commit to advancing mechanical circulatory support, closing the gap caused by the donor heart shortage, and providing hope to those who have exhausted other options. We aim to be the national leader in TAH outcomes and the primary partner for the U.S. cardiac care community, driving measurable improvements in survival and quality of life.
Success hinges on clinical excellence, technical capacity, referral flow, financial performance, and formal accreditation.
The institute forecasts rapid revenue and cash-profit growth driven by high-value TAH procedures and specialized services.
Ratio |
2026 |
2027 |
2028 |
Projected Revenue |
$12,919,000 |
$26,106,000 |
$44,238,000 |
Projected EBITDA |
$8,255,000 |
$18,904,000 |
$33,856,000 |
Expected ROI |
IRR 12.66% · ROE 181.26% |
IRR 12.66% · ROE 181.26% |
IRR 12.66% · ROE 181.26% |
Financial requirements: $8,750,000 initial CapEx; minimum cash reached -$3,387,000 (Jun-26); breakeven Jan-26; 15-month payback for initial investments. Expected investor return: IRR 12.66% and ROE 181.26%.
Overall outlook: strong profitability and cash generation from Year 1 through Year 5.
Secure $12,500,000 now to fund $8,750,000 in capital expenditures and $3,387,000 of liquidity through the June 2026 cash low point.
Categories |
Amount, USD |
Facility renovations and sterile rooms |
3,000,000 |
Hybrid operating room suite |
2,500,000 |
TAH external driver inventory (initial) |
450,000 |
Diagnostic imaging equipment |
1,200,000 |
Cardiac ICU monitoring systems |
850,000 |
Backup power and life support systems |
350,000 |
Remote patient monitoring hub |
150,000 |
Mobile emergency response unit |
200,000 |
CapEx contingency |
50,000 |
Working capital (minimum cash deficit) |
3,387,000 |
Total funding required |
12,500,000 |
A completed, industry-specific Word business plan for evaluating and presenting a Total Artificial Heart program built around surgical implantation, intensive recovery, outpatient device management, referral development, specialized staffing, infrastructure, funding, and financial performance. Buyers can rewrite and tailor every part for their own organization and assumptions.
The plan connects the program's high-value clinical services with referral development, specialized operating requirements, staffing, organization, milestones, and the financial case needed to evaluate funding and execution.
The completed Word plan is fully editable throughout, so you can retain the industry-specific structure while replacing sample facts, organization details, services, market assumptions, staffing, milestones, and financial inputs with verified information for your program.
Use the free PDF to evaluate selected content and presentation; choose the paid Word document when you need the six complete sections and full editing control.
The sample is for evaluation; the paid product is the complete editable Word business plan delivered after purchase.
Answers below cover what is already written, how the Word document can be edited, which financial content is included, how the free preview differs, and how the plan can support investor, lender, and internal planning discussions.
It is a pre-written, industry-specific business plan, not a blank outline. The document is structured around a Total Artificial Heart program and can be revised for your own organization.
You receive a fully editable Microsoft Word document through instant download after purchase. Every part can be rewritten, expanded, deleted, rearranged, or reformatted.
It addresses the full clinical pathway described in the Executive Summary, including patient evaluation, TAH implantation, ICU and step-down recovery, outpatient device management, device servicing, remote monitoring, local-provider training, and referral development.
The complete plan includes P&L, cash flow, balance sheet, break-even, revenue forecast, startup and funding assumptions, and financial KPIs. Sample figures should be reviewed and replaced with your own verified assumptions where appropriate.
The free file is a 10-page, read-only, watermarked evaluation preview with selected content. The paid product provides all six complete business-plan sections in a fully editable Microsoft Word document.
Yes, the plan is intended for investor presentations, lender discussions, and internal business planning. You can adapt company details, services, customers, market strategy, staffing, operations, financial figures, funding assumptions, and presentation content.
Yes, the source material addresses specialized clinical staffing and technical infrastructure, including cardiac surgeons, critical care nurses, a hybrid operating room, diagnostic and ICU systems, device inventory, and remote patient monitoring. Those sample details are editable for your own program.
Yes, you can optionally upload the already written Word plan to ChatGPT or Claude and personalize selected sections. AI tools are not included, and you should review every change and replace sample facts and financial assumptions with verified information.
Use the free PDF and live Executive Summary to evaluate the plan first, then choose the complete editable Word document when you are ready to tailor all six sections for your own Total Artificial Heart program.
This product includes a comprehensive, pre-written business plan in an editable Microsoft Word file, complete with integrated financial forecast tables.
Your concept at a glance
What you sell and why
Market size and rivals
Channels, promotions, conversions
Team roles and org chart
P&L cash flow break-even
Edit fast on any device
All core chapters included
I had no business-plan experience, and this gave me a clean way to organize the story from start to finish. I went from scattered notes to a usable draft in one evening.
Hiring a consultant felt out of reach, so this template was a relief. It saved me around $2,000 and still gave me a polished plan I could edit in Word.
The market research sections kept me from drowning in customer and competitor data. I saved hours by filling in the prompts and ended up with a much clearer plan.
